Mary Wilson
New member
The Food and Drug Administration (FDA) advises the public against the purchase and use of the counterfeit Anti-Rabies Serum (Equine) Equirab 200 IU/mL (1000 IU/5 mL) Solution for Injection (I.M./S.C.):
The FDA together with the Marketing Authorization Holder (MAH), BSV Bio Science Phils., Inc., have verified that the above-mentioned sample drug product is counterfeit.
All healthcare professionals and the general public are hereby warned as to the availability of this counterfeit drug product in the market which poses potential danger or injury to consumers. Consumers are also reminded to purchase drug products only from FDA-licensed establishments.
Likewise, all establishments and outlets are hereby warned against selling and/or dispensing of this drug product with the abovementioned features of a counterfeit drug product. The importation, selling or offering for sale of such is in direct violation of Republic Act No. 9711 or the Food and Drug Administration Act of 2009, and Republic Act No. 8203 or the Special Law on Counterfeit Drugs. Anyone found selling the said counterfeit drug product will be penalized. ...
https://www.fda.gov.ph/fda-advisory...-1000-iu-5-ml-solution-for-injection-i-m-s-c/
Attachments
https://www.fda.gov.ph/wp-content/uploads/2021/08/FDA-Advisory-No.2021-1925.pdf
The FDA together with the Marketing Authorization Holder (MAH), BSV Bio Science Phils., Inc., have verified that the above-mentioned sample drug product is counterfeit.
All healthcare professionals and the general public are hereby warned as to the availability of this counterfeit drug product in the market which poses potential danger or injury to consumers. Consumers are also reminded to purchase drug products only from FDA-licensed establishments.
Likewise, all establishments and outlets are hereby warned against selling and/or dispensing of this drug product with the abovementioned features of a counterfeit drug product. The importation, selling or offering for sale of such is in direct violation of Republic Act No. 9711 or the Food and Drug Administration Act of 2009, and Republic Act No. 8203 or the Special Law on Counterfeit Drugs. Anyone found selling the said counterfeit drug product will be penalized. ...
https://www.fda.gov.ph/fda-advisory...-1000-iu-5-ml-solution-for-injection-i-m-s-c/
Attachments
https://www.fda.gov.ph/wp-content/uploads/2021/08/FDA-Advisory-No.2021-1925.pdf